February 2003
Volume 27 No. 2


Hi-tech ID wristbands boost safety, efficiency

New policy details procedure for missing patients

New Cellular Therapeutics Lab boosts SHC's bone marrow transplant capacity

Emergency Medicine faculty promotes specialty halfway around the globe

Revised policies mean cell phones, laptops can be used in some areas

Physicians can take simple steps to improve patient safety

 

 

 

 


Tell us about your awards and accomplishments, or those of your colleagues. Send your contributions to Sara Selis by e-mail selis@stanford.edu or fax (650) 723-7172, or call her at (650) 723-7798.


LINDA C. GIUDICE, chief of reproductive endocrinology and infertility in the Department of Obstetrics and Gynecology, was named chair of the U.S. Food and Drug Administration's Advisory Committee for Reproductive Health Drugs. The appointment of Giudice and 10 new members will revive the committee, which has not met for two years and has seen its entire membership lapse. The committee makes recommendations to FDA Commissioner Mark McClellan, a Stanford associate professor of economics and of medicine who has been on leave since spring 2001. Giudice, who directs Women's Health @ Stanford, said one of the first issues the committee will examine is menopausal hormone replacement therapy, given recent studies that have questioned its safety and effectiveness.

JOACHIM F. HALLMAYER was appointed associate professor (research) of psychiatry and behavioral sciences. Hallmayer is an internationally renowned scientist in psychiatric genetics and neurogenetics. His research focuses on identifying genes associated with psychiatric disorders such as schizophrenia and autism. From 1989 to 1994 he worked at Stanford with genetics professor Luigi L. Cavalli-Sforza, first as a fellow with the German Research Association and then as a researcher for the National Alliance for Research in Schizophrenia and Depression. He was associate professor of psychiatry at the University of Western Australia from 1995 to 2001, when he returned to Stanford as acting professor.

PAUL A. KHAVARI was promoted to professor of dermatology. A nationally recognized epidermal biologist, Khavari conducts research in the cutaneous delivery of genes; gene therapy relating to skin disorders such as epidermolysis bullosa; and the regulatory mechanisms of genes in epithelial cells. He has served since 1993 as chief of dermatology at the Veterans Affairs Palo Alto Health Care System. An alumnus of Stanford University, he received his MD from Yale University and returned to the Stanford School of Medicine to study gene regulation, earning a PhD in 1993 and an appointment as assistant professor of dermatology. He was promoted to associate professor, with tenure, in 1998.

IRIS F. LITT, chief of the division of adolescent medicine at Lucile Packard Children's Hospital, was appointed national director of the Robert Wood Johnson Foundation's Clinical Scholars Program. The program sponsors young physicians during two- and three-year post-residency fellowships in the non-biological aspects of medical care, including health-care delivery and financing, biomedical ethics and clinical decision-making. Litt's first task as the national director will be to develop a core curriculum, which will include leadership training and community-based research for each of seven training sites nationwide. Her research focuses on adolescent health behavior and the prevention, diagnosis and treatment of anorexia nervosa.

MARY LAKE POLAN, chair of the obstetrics and gynecology department, was named a member of the federal Department of Health and Human Services Secretary's Advisory Committee on Human Research Protection. The committee of 11 members, named Jan. 3, advises HHS Secretary Tommy G. Thompson on matters relating to research involving human subjects. The committee's goal represents an expansion of the responsibilities held by the department's previous advisory committee on human subjects. Its mission now includes consideration of embryos and fetuses as human subjects - a Bush administration decision that has led to heated public debate. Polan, who holds Stanford's Katharine Dexter McCormick and Stanley McCormick professorship, said she's looking forward to the challenge of serving on the committee.

NORMAN H. SILVERMAN was appointed professor of pediatrics (pediatric cardiology) at Lucile Packard Children's Hospital. An internationally recognized pediatric echocardiographer and a founder of the subspecialty, Silverman pioneered the techniques of echocardiography for congenital heart disease and the development of fetal echocardiography. He joins Stanford from UC-San Francisco, where he held faculty appointments in pediatrics and radiology for more than two decades. While at UCSF, he created a premier program in anatomical-based cardiac imaging, combining detailed studies of cardiac anatomical pathology with noninvasive imaging. He received the American Society of Echocardiography Founder's Award and the Ultrasound in Medicine and Biology Clinical Prize in 2000. He served as president of the California Society of Pediatric Cardiology from 2000 to 2001.